Tower Research Capital (TRC)’s ProMIS Neurosciences PMN Stock Holding History
Bought
Maintained
Sold
Other funds holding PMN
YF
6CM
Tower Research Capital (TRC)'s PMN Position: Q3 2026 in Review
Tower Research Capital (TRC) opened a new position in ProMIS Neurosciences (PMN) in Q3 2026: 33 shares worth $358. The stake represents ﹤0.01% of the portfolio and ranks #5606 among its holdings. This is a return to the name: Tower Research Capital (TRC) previously reported a position in PMN as recently as Q4 2025.
Tower Research Capital (TRC) first reported a position in PMN in Q4 2025 and has held it in 2 quarters since. 30 funds tracked by Wall St. Rank hold PMN as of Q3 2026.
- Tower Research Capital (TRC) held 33 shares of ProMIS Neurosciences worth $358 as of Q3 2026.
- ProMIS Neurosciences was a new Tower Research Capital (TRC) position in Q3 2026.
- ProMIS Neurosciences made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #5606 holding.
- Tower Research Capital (TRC) first reported a position in ProMIS Neurosciences in Q4 2025 and has held it in 2 quarters since.
- 30 funds tracked by Wall St. Rank held ProMIS Neurosciences as of Q3 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.